Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis

Lama A. Noureddine, Sohail A. Usman, Zhangsheng Yu, Ranjani Moorthi, Sharon Moe

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background/Aims: We have shown that hepatitis C does not increase the risk of developing chronic kidney disease (CKD), but it is not known if hepatitis C worsens progression of existing CKD. Methods: We retrospectively identified patients with primary glomerulonephritis on biopsy over 4 years, evaluating the progression of CKD over time. Results: The cohort consisted of 111 patients: 21% were positive for hepatitis C, 61% were negative for hepatitis C and 18% were not tested. The hepatitis C-positive subjects were more likely to be African American (p = 0.031), followed for fewer days (p = 0.007) and have diabetes and focal segmental glomerulosclerosis on biopsy (p < 0.001). Longitudinal follow-up of CKD progression using multiple creatinine measures analyzed by repeated measures ANCOVA demonstrated that patients with hepatitis C had a worsening creatinine over time compared to the hepatitis C-negative and not tested groups (p < 0.001). By Cox hazards regression analyses, risk of death/end-stage renal disease (ESRD) was decreased in patients who tested negative for hepatitis C compared to testing positive (0.46, CI 0.27-0.88), but this became nonsignificant after adjustment for mean arterial pressure and hemoglobin. Conclusion: Our results support that infection with hepatitis C in patients with glomerulonephritis is associated with an increased risk of progression of CKD. Prospective studies are required to confirm these observations.

Original languageEnglish
Pages (from-to)311-316
Number of pages6
JournalAmerican Journal of Nephrology
Volume32
Issue number4
DOIs
StatePublished - Oct 2010

Fingerprint

Hepatitis C
Glomerulonephritis
Chronic Renal Insufficiency
Creatinine
Biopsy
Focal Segmental Glomerulosclerosis
African Americans
Chronic Kidney Failure
Disease Progression
Arterial Pressure
Hemoglobins
Regression Analysis
Prospective Studies
Infection

Keywords

  • Chronic kidney disease
  • Diabetic nephropathy
  • Dialysis
  • Focal segmental glomerulosclerosis
  • Glomerulonephritis
  • Hepatitis C

ASJC Scopus subject areas

  • Nephrology

Cite this

Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. / Noureddine, Lama A.; Usman, Sohail A.; Yu, Zhangsheng; Moorthi, Ranjani; Moe, Sharon.

In: American Journal of Nephrology, Vol. 32, No. 4, 10.2010, p. 311-316.

Research output: Contribution to journalArticle

@article{8d9324a1371b401eb8fe61f59054e2f1,
title = "Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis",
abstract = "Background/Aims: We have shown that hepatitis C does not increase the risk of developing chronic kidney disease (CKD), but it is not known if hepatitis C worsens progression of existing CKD. Methods: We retrospectively identified patients with primary glomerulonephritis on biopsy over 4 years, evaluating the progression of CKD over time. Results: The cohort consisted of 111 patients: 21{\%} were positive for hepatitis C, 61{\%} were negative for hepatitis C and 18{\%} were not tested. The hepatitis C-positive subjects were more likely to be African American (p = 0.031), followed for fewer days (p = 0.007) and have diabetes and focal segmental glomerulosclerosis on biopsy (p < 0.001). Longitudinal follow-up of CKD progression using multiple creatinine measures analyzed by repeated measures ANCOVA demonstrated that patients with hepatitis C had a worsening creatinine over time compared to the hepatitis C-negative and not tested groups (p < 0.001). By Cox hazards regression analyses, risk of death/end-stage renal disease (ESRD) was decreased in patients who tested negative for hepatitis C compared to testing positive (0.46, CI 0.27-0.88), but this became nonsignificant after adjustment for mean arterial pressure and hemoglobin. Conclusion: Our results support that infection with hepatitis C in patients with glomerulonephritis is associated with an increased risk of progression of CKD. Prospective studies are required to confirm these observations.",
keywords = "Chronic kidney disease, Diabetic nephropathy, Dialysis, Focal segmental glomerulosclerosis, Glomerulonephritis, Hepatitis C",
author = "Noureddine, {Lama A.} and Usman, {Sohail A.} and Zhangsheng Yu and Ranjani Moorthi and Sharon Moe",
year = "2010",
month = "10",
doi = "10.1159/000319456",
language = "English",
volume = "32",
pages = "311--316",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis

AU - Noureddine, Lama A.

AU - Usman, Sohail A.

AU - Yu, Zhangsheng

AU - Moorthi, Ranjani

AU - Moe, Sharon

PY - 2010/10

Y1 - 2010/10

N2 - Background/Aims: We have shown that hepatitis C does not increase the risk of developing chronic kidney disease (CKD), but it is not known if hepatitis C worsens progression of existing CKD. Methods: We retrospectively identified patients with primary glomerulonephritis on biopsy over 4 years, evaluating the progression of CKD over time. Results: The cohort consisted of 111 patients: 21% were positive for hepatitis C, 61% were negative for hepatitis C and 18% were not tested. The hepatitis C-positive subjects were more likely to be African American (p = 0.031), followed for fewer days (p = 0.007) and have diabetes and focal segmental glomerulosclerosis on biopsy (p < 0.001). Longitudinal follow-up of CKD progression using multiple creatinine measures analyzed by repeated measures ANCOVA demonstrated that patients with hepatitis C had a worsening creatinine over time compared to the hepatitis C-negative and not tested groups (p < 0.001). By Cox hazards regression analyses, risk of death/end-stage renal disease (ESRD) was decreased in patients who tested negative for hepatitis C compared to testing positive (0.46, CI 0.27-0.88), but this became nonsignificant after adjustment for mean arterial pressure and hemoglobin. Conclusion: Our results support that infection with hepatitis C in patients with glomerulonephritis is associated with an increased risk of progression of CKD. Prospective studies are required to confirm these observations.

AB - Background/Aims: We have shown that hepatitis C does not increase the risk of developing chronic kidney disease (CKD), but it is not known if hepatitis C worsens progression of existing CKD. Methods: We retrospectively identified patients with primary glomerulonephritis on biopsy over 4 years, evaluating the progression of CKD over time. Results: The cohort consisted of 111 patients: 21% were positive for hepatitis C, 61% were negative for hepatitis C and 18% were not tested. The hepatitis C-positive subjects were more likely to be African American (p = 0.031), followed for fewer days (p = 0.007) and have diabetes and focal segmental glomerulosclerosis on biopsy (p < 0.001). Longitudinal follow-up of CKD progression using multiple creatinine measures analyzed by repeated measures ANCOVA demonstrated that patients with hepatitis C had a worsening creatinine over time compared to the hepatitis C-negative and not tested groups (p < 0.001). By Cox hazards regression analyses, risk of death/end-stage renal disease (ESRD) was decreased in patients who tested negative for hepatitis C compared to testing positive (0.46, CI 0.27-0.88), but this became nonsignificant after adjustment for mean arterial pressure and hemoglobin. Conclusion: Our results support that infection with hepatitis C in patients with glomerulonephritis is associated with an increased risk of progression of CKD. Prospective studies are required to confirm these observations.

KW - Chronic kidney disease

KW - Diabetic nephropathy

KW - Dialysis

KW - Focal segmental glomerulosclerosis

KW - Glomerulonephritis

KW - Hepatitis C

UR - http://www.scopus.com/inward/record.url?scp=77955532272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955532272&partnerID=8YFLogxK

U2 - 10.1159/000319456

DO - 10.1159/000319456

M3 - Article

C2 - 20714136

AN - SCOPUS:77955532272

VL - 32

SP - 311

EP - 316

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 4

ER -